Cargando…
Prediction of Cerebral Amyloid Pathology Based on Plasma Amyloid and Tau Related Markers
Background and Purpose: Pyroglutamate-modified β-amyloid peptide (Aβ(pE)) is crucial for AD pathophysiological process. The potential associations of plasma Aβ(pE) and total tau (t-tau) with brain Aβ burden and cognitive performance remain to be clarified. Methods: Forty-six subjects with unimpaired...
Autores principales: | Chen, Ting-Bin, Lin, Kun-Ju, Lin, Szu-Ying, Lee, Yi-Jung, Lin, Yi-Cheng, Wang, Chen-Yu, Chen, Jun-Peng, Wang, Pei-Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520900/ https://www.ncbi.nlm.nih.gov/pubmed/34671305 http://dx.doi.org/10.3389/fneur.2021.619388 |
Ejemplares similares
-
Plasma pyroglutamate‐modified amyloid beta differentiates amyloid pathology
por: Wang, Pei‐Ning, et al.
Publicado: (2020) -
Amyloid and tau PET in cerebral amyloid angiopathy-related inflammation two case reports and literature review
por: Yang, Jhih-Yong, et al.
Publicado: (2023) -
Plasma Amyloid Beta and Tau Levels Are Predictors of Post-stroke Cognitive Impairment: A Longitudinal Study
por: Chi, Nai-Fang, et al.
Publicado: (2019) -
Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition
por: Risacher, Shannon L., et al.
Publicado: (2019) -
Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer’s disease
por: Lin, Szu-Ying, et al.
Publicado: (2019)